{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T10:38:37Z","timestamp":1753439917191},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,10,15]],"date-time":"2014-10-15T00:00:00Z","timestamp":1413331200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s12883-014-0202-3","type":"journal-article","created":{"date-parts":[[2014,10,14]],"date-time":"2014-10-14T14:37:48Z","timestamp":1413297468000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Changes in lymphocyte subsets in patients with Guillain-Barr\u00e9 syndrome treated with immunoglobulin"],"prefix":"10.1186","volume":"14","author":[{"given":"Hui Qing","family":"Hou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue Dan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu Juan","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,15]]},"reference":[{"issue":"1","key":"202_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1473-3099(01)00019-6","volume":"1","author":"N Yuki","year":"2001","unstructured":"Yuki N: Infectious origins of, and molecular mimicry in, Guillain-Barre and Fisher syndromes. Lancet Infect Dis. 2001, 1 (1): 29-37. 10.1016\/S1473-3099(01)00019-6.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"202_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jnr.20395","volume":"80","author":"T Ariga","year":"2005","unstructured":"Ariga T, Yu RK: Antiglycolipid antibodies in Guillain-Barre syndrome and related diseases: review of clinical features and antibody specificities. J Neurosci Res. 2005, 80 (1): 1-17. 10.1002\/jnr.20395.","journal-title":"J Neurosci Res"},{"issue":"Pt 3","key":"202_CR3","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1093\/brain\/118.3.577","volume":"118","author":"JW Griffin","year":"1995","unstructured":"Griffin JW, Li CY, Ho TW, Xue P, Macko C, Gao CY, Yang C, Tian M, Mishu B, Cornblath DR: Guillain-Barre syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. Brain. 1995, 118 (Pt 3): 577-595. 10.1093\/brain\/118.3.577.","journal-title":"Brain"},{"issue":"Pt 9","key":"202_CR4","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1093\/brain\/awm004","volume":"130","author":"RA Hughes","year":"2007","unstructured":"Hughes RA, Swan AV, Raphael JC, Annane D, van Koningsveld R, van Doorn PA: Immunotherapy for Guillain-Barre syndrome: a systematic review. Brain. 2007, 130 (Pt 9): 2245-2257. 10.1093\/brain\/awm004.","journal-title":"Brain"},{"issue":"2","key":"202_CR5","first-page":"87","volume":"41","author":"L Guo","year":"2008","unstructured":"Guo L, Hou HQ, Song XJ, Yang JC, Gao CY: Change of T-Lymphocyte subsets in the patients with Gullain-Barre syndrome between pre and post-therapy with intravenous immunoglobulin and its meaning. Chin J Neurol. 2008, 41 (2): 87-90.","journal-title":"Chin J Neurol"},{"issue":"2","key":"202_CR6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0165-5728(94)90032-9","volume":"53","author":"C Dahle","year":"1994","unstructured":"Dahle C, Vrethem M, Ernerudh J: T lymphocyte subset abnormalities in peripheral blood from patients with the Guillain-Barre syndrome. J Neuroimmunol. 1994, 53 (2): 219-225. 10.1016\/0165-5728(94)90032-9.","journal-title":"J Neuroimmunol"},{"issue":"1","key":"202_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0022-510X(97)00082-8","volume":"151","author":"E Sindern","year":"1997","unstructured":"Sindern E, Oreja-Guevara C, Raulf-Heimsoth M, Baur X, Malin JP: A longitudinal study of circulating lymphocyte subsets in the peripheral blood during the acute stage of Guillain-Barre syndrome. J Neurol Sci. 1997, 151 (1): 29-34. 10.1016\/S0022-510X(97)00082-8.","journal-title":"J Neurol Sci"},{"issue":"3","key":"202_CR8","first-page":"448","volume":"51","author":"RA Hughes","year":"1983","unstructured":"Hughes RA, Aslan S, Gray IA: Lymphocyte subpopulations and suppressor cell activity in acute polyradiculoneuritis (Guillain-Barre syndrome). Clin Exp Immunol. 1983, 51 (3): 448-454.","journal-title":"Clin Exp Immunol"},{"issue":"2-3","key":"202_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0165-5728(85)80050-3","volume":"8","author":"RP Lisak","year":"1985","unstructured":"Lisak RP, Zweiman B, Guerrero F, Moskovitz AR: Circulating T-cell subsets in Guillain-Barre syndrome. J Neuroimmunol. 1985, 8 (2-3): 93-101. 10.1016\/S0165-5728(85)80050-3.","journal-title":"J Neuroimmunol"},{"issue":"8","key":"202_CR10","first-page":"583","volume":"43","author":"LY Cui","year":"2010","unstructured":"Cui LY, Pu CQ, Hu XQ: The diagnosis and treatment guidelines of Guillain-Barre syndrome in China. Chin J Neurol. 2010, 43 (8): 583-586.","journal-title":"Chin J Neurol"},{"issue":"Suppl","key":"202_CR11","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1002\/ana.410270707","volume":"27","author":"AK Asbury","year":"1990","unstructured":"Asbury AK, Cornblath DR: Assessment of current diagnostic criteria for Guillain-Barre syndrome. Ann Neurol. 1990, 27 (Suppl): S21-S24. 10.1002\/ana.410270707.","journal-title":"Ann Neurol"},{"issue":"4","key":"202_CR12","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/mus.20022","volume":"29","author":"PY Van den Bergh","year":"2004","unstructured":"Van den Bergh PY, Pieret F: Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve. 2004, 29 (4): 565-574. 10.1002\/mus.20022.","journal-title":"Muscle Nerve"},{"issue":"3","key":"202_CR13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1159\/000052111","volume":"45","author":"FG Van der Meche","year":"2001","unstructured":"Van der Meche FG, Van Doorn PA, Meulstee J, Jennekens FG: Diagnostic and classification criteria for the Guillain-Barre syndrome. Eur Neurol. 2001, 45 (3): 133-139. 10.1159\/000052111.","journal-title":"Eur Neurol"},{"issue":"2","key":"202_CR14","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4103\/0022-3859.52846","volume":"55","author":"KS Puri","year":"2009","unstructured":"Puri KS, Suresh KR, Gogtay NJ, Thatte UM: Declaration of Helsinki, 2008: implications for stakeholders in research. J Postgrad Med. 2009, 55 (2): 131-134. 10.4103\/0022-3859.52846.","journal-title":"J Postgrad Med"},{"issue":"8093","key":"202_CR15","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","volume":"2","author":"RA Hughes","year":"1978","unstructured":"Hughes RA, Newsom-Davis JM, Perkin GD, Pierce JM: Controlled trial prednisolone in acute polyneuropathy. Lancet. 1978, 2 (8093): 750-753. 10.1016\/S0140-6736(78)92644-2.","journal-title":"Lancet"},{"issue":"2","key":"202_CR16","first-page":"154","volume":"37","author":"M Peng","year":"2004","unstructured":"Peng M, Jia JP: Predictors at nadir of severity on patients with Guillain-Barre syndrome. Chin J Neurol. 2004, 37 (2): 154-157.","journal-title":"Chin J Neurol"},{"issue":"3","key":"202_CR17","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/00005792-196905000-00001","volume":"48","author":"AK Asbury","year":"1969","unstructured":"Asbury AK, Arnason BG, Adams RD: The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis. Medicine (Baltimore). 1969, 48 (3): 173-215. 10.1097\/00005792-196905000-00001.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"202_CR18","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/ana.410390512","volume":"39","author":"CE Hafer-Macko","year":"1996","unstructured":"Hafer-Macko CE, Sheikh KA, Li CY, Ho TW, Cornblath DR, McKhann GM, Asbury AK, Griffin JW: Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol. 1996, 39 (5): 625-635. 10.1002\/ana.410390512.","journal-title":"Ann Neurol"},{"issue":"Pt 6","key":"202_CR19","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/brain\/109.6.1115","volume":"109","author":"TE Feasby","year":"1986","unstructured":"Feasby TE, Gilbert JJ, Brown WF, Bolton CF, Hahn AF, Koopman WF, Zochodne DW: An acute axonal form of Guillain-Barre polyneuropathy. Brain. 1986, 109 (Pt 6): 1115-1126. 10.1093\/brain\/109.6.1115.","journal-title":"Brain"},{"issue":"2","key":"202_CR20","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0022-510X(93)90324-R","volume":"116","author":"TE Feasby","year":"1993","unstructured":"Feasby TE, Hahn AF, Brown WF, Bolton CF, Gilbert JJ, Koopman WJ: Severe axonal degeneration in acute Guillain-Barre syndrome: evidence of two different mechanisms?. J Neurol Sci. 1993, 116 (2): 185-192. 10.1016\/0022-510X(93)90324-R.","journal-title":"J Neurol Sci"},{"issue":"6","key":"202_CR21","doi-asserted-by":"publisher","first-page":"e67185","DOI":"10.1371\/journal.pone.0067185","volume":"8","author":"SK Greene","year":"2013","unstructured":"Greene SK, Rett MD, Vellozzi C, Li L, Kulldorff M, Marcy SM, Daley MF, Belongia EA, Baxter R, Fireman BH, Jackson ML, Omer SB, Nordin JD, Jin R, Weintraub ES, Vijayadeva V, Lee GM: Guillain-Barre syndrome, influenza vaccination, and antecedent respiratory and gastrointestinal infections: a case-centered analysis in the vaccine safety datalink, 2009-2011. PLoS ONE. 2013, 8 (6): e67185-10.1371\/journal.pone.0067185.","journal-title":"PLoS ONE"},{"issue":"2","key":"202_CR22","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/CND.0b013e31824db14e","volume":"14","author":"N Souayah","year":"2012","unstructured":"Souayah N, Yacoub HA, Khan HM, Farhad K, Mehyar LS, Maybodi L, Menkes DL, Qureshi AI: Guillain-Barre syndrome after influenza vaccination in the United States, a report from the CDC\/FDA vaccine adverse event reporting system (1990-2009). J Clin Neuromuscul Dis. 2012, 14 (2): 66-71. 10.1097\/CND.0b013e31824db14e.","journal-title":"J Clin Neuromuscul Dis"},{"key":"202_CR23","doi-asserted-by":"publisher","first-page":"d3908","DOI":"10.1136\/bmj.d3908","volume":"343","author":"J Dieleman","year":"2011","unstructured":"Dieleman J, Romio S, Johansen K, Weibel D, Bonhoeffer J, Sturkenboom M: Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe. BMJ. 2011, 343: d3908-10.1136\/bmj.d3908.","journal-title":"BMJ"},{"issue":"10","key":"202_CR24","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(08)70215-1","volume":"7","author":"PA van Doorn","year":"2008","unstructured":"van Doorn PA, Ruts L, Jacobs BC: Clinical features, pathogenesis, and treatment of Guillain-Barre syndrome. Lancet Neurol. 2008, 7 (10): 939-950. 10.1016\/S1474-4422(08)70215-1.","journal-title":"Lancet Neurol"},{"issue":"3","key":"202_CR25","first-page":"249","volume":"80","author":"MP Lunn","year":"2009","unstructured":"Lunn MP, Willison HJ: Diagnosis and treatment in inflammatory neuropathies. J Neurol Neurosurg Psychiatry. 2009, 80 (3): 249-258.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"202_CR26","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1136\/jnnp.2010.226639","volume":"82","author":"J Drenthen","year":"2011","unstructured":"Drenthen J, Yuki N, Meulstee J, Maathuis EM, van Doorn PA, Visser GH, Blok JH, Jacobs BC: Guillain-Barre syndrome subtypes related to Campylobacter infection. J Neurol Neurosurg Psychiatry. 2011, 82 (3): 300-305. 10.1136\/jnnp.2010.226639.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"202_CR27","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.4049\/jimmunol.170.6.3074","volume":"170","author":"EE Magira","year":"2003","unstructured":"Magira EE, Papaioakim M, Nachamkin I, Asbury AK, Li CY, Ho TW, Griffin JW, McKhann GM, Monos DS: Differential distribution of HLA-DQ beta\/DR beta epitopes in the two forms of Guillain-Barre syndrome, acute motor axonal neuropathy and acute inflammatory demyelinating polyneuropathy (AIDP): identification of DQ beta epitopes associated with susceptibility to and protection from AIDP. J Immunol. 2003, 170 (6): 3074-3080. 10.4049\/jimmunol.170.6.3074.","journal-title":"J Immunol"},{"issue":"9","key":"202_CR28","doi-asserted-by":"publisher","first-page":"4091","DOI":"10.1128\/JVI.75.9.4091-4102.2001","volume":"75","author":"S McBreen","year":"2001","unstructured":"McBreen S, Imlach S, Shirafuji T, Scott GR, Leen C, Bell JE, Simmonds P: Infection of the CD45RA+ (naive) subset of peripheral CD8+ lymphocytes by human immunodeficiency virus type 1 in vivo. J Virol. 2001, 75 (9): 4091-4102. 10.1128\/JVI.75.9.4091-4102.2001.","journal-title":"J Virol"},{"issue":"1","key":"202_CR29","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4049\/jimmunol.145.1.102","volume":"145","author":"LT Clement","year":"1990","unstructured":"Clement LT, Vink PE, Bradley GE: Novel immunoregulatory functions of phenotypically distinct subpopulations of CD4+ cells in the human neonate. J Immunol. 1990, 145 (1): 102-108.","journal-title":"J Immunol"},{"issue":"1-2","key":"202_CR30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.imlet.2003.10.018","volume":"92","author":"L McNeill","year":"2004","unstructured":"McNeill L, Cassady RL, Sarkardei S, Cooper JC, Morgan G, Alexander DR: CD45 isoforms in T cell signalling and development. Immunol Lett. 2004, 92 (1-2): 125-134. 10.1016\/j.imlet.2003.10.018.","journal-title":"Immunol Lett"},{"issue":"6","key":"202_CR31","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/j.1365-3083.2005.01624.x","volume":"61","author":"M Matto","year":"2005","unstructured":"Matto M, Nuutinen UM, Ropponen A, Myllykangas K, Pelkonen J: CD45RA and RO isoforms have distinct effects on cytokine- and B-cell-receptor-mediated signalling in human B cells. Scand J Immunol. 2005, 61 (6): 520-528. 10.1111\/j.1365-3083.2005.01624.x.","journal-title":"Scand J Immunol"},{"issue":"8","key":"202_CR32","doi-asserted-by":"publisher","first-page":"4317","DOI":"10.4049\/jimmunol.0903781","volume":"184","author":"NJ Booth","year":"2010","unstructured":"Booth NJ, McQuaid AJ, Sobande T, Kissane S, Agius E, Jackson SE, Salmon M, Falciani F, Yong K, Rustin MH, Akbar AN, Vukmanovic-Stejic M: Different proliferative potential and migratory characteristics of human CD4+ regulatory T cells that express either CD45RA or CD45RO. J Immunol. 2010, 184 (8): 4317-4326. 10.4049\/jimmunol.0903781.","journal-title":"J Immunol"},{"issue":"9497","key":"202_CR33","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","volume":"366","author":"RA Hughes","year":"2005","unstructured":"Hughes RA, Cornblath DR: Guillain-Barre syndrome. Lancet. 2005, 366 (9497): 1653-1666. 10.1016\/S0140-6736(05)67665-9.","journal-title":"Lancet"},{"issue":"10","key":"202_CR34","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1586\/14737175.6.10.1569","volume":"6","author":"MR Douglas","year":"2006","unstructured":"Douglas MR, Winer JB: Guillain-Barre syndrome and its treatment. Expert Rev Neurother. 2006, 6 (10): 1569-1574. 10.1586\/14737175.6.10.1569.","journal-title":"Expert Rev Neurother"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-014-0202-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-014-0202-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-014-0202-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-014-0202-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T07:39:04Z","timestamp":1689579544000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-014-0202-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,15]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["202"],"URL":"https:\/\/doi.org\/10.1186\/s12883-014-0202-3","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,15]]},"assertion":[{"value":"30 August 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"202"}}